Clinical Guide

The Enhanced Liver Fibrosis (ELF) Test

The ELF Test is a simple blood test that can assess the risk of disease progression in patients with advanced fibrosis due to nonalcoholic steatohepatitis (NASH).

Download the clinical guide to learn how the ELF Test works, and the clinical value of prognostic testing.

Fill out the form below to download the Guide “The Enhanced Liver Fibrosis (ELF) Test” and sign up for our email list around related topics.

To receive the document for free, please fill out the form below. In return, we will provide you the Guide: The Enhanced Liver Fibrosis (ELF) Test and further marketing communication. The information you provide below will be processed as described further in the Privacy Notice.

Have a question? Talk to sales.

From the guide What patients are at a higher risk of developing or having NAFLD?

BMI ≥ 30
60-95% also have NAFLD
Heart Disease
69% also have NAFLD
Type 2 Diabetes
50-74% also have NAFLD
Hypertension
50-74% also have NAFLD

2 or more features of metabolic syndrome have a 90% chance of having NAFLD